Pyrazole derivatives as protein kinase modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9283226
APP PUB NO 20140271662A1
SERIAL NO

14180440

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides compounds of the formula (I) having protein kinase B inhibiting activity:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CANCER RESEARCH TECHNOLOGY LIMITEDANGEL BUILDING 407 ST JOHN STREET LONDON EC1V4AD
ASTEX THERAPEUTICS LIMITEDCAMBRIDGE CAMBRIDGESHIRE CB4 0QA
THE INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL123 OLD BROMPTON ROAD LONDON SW7 3RP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berdini, Valerio Cambridge, GB 63 1305
Boyle, Robert George Cambridge, GB 36 393
Carr, Robin Arthur Ellis Bassingbourn, GB 9 81
Collins, Ian Redhill, GB 93 1712
Downham, Robert Newmarket, GB 25 140
Saxty, Gordon Cambridge, GB 55 1129
Sore, Hannah Fiona Cambridge, GB 11 102
Verdonk, Marinus Leendert Burwell, GB 13 119
Walker, David Winter Linton, GB 25 158
Woodhead, Steven John Cambridge, GB 32 655
Wyatt, Paul Graham Perth, GB 40 681

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00